Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.

Saved in:

Bibliographic Details
Title:	Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region.
Authors:	Nieder C; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway. carsten.nieder@nlsh.no.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway. carsten.nieder@nlsh.no., Syed MA; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway.; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway., Pawinski A; Department of Oncology and Palliative Medicine, Nordland Hospital, 8092, Bodø, Norway., Norum J; Department of Clinical Medicine, Faculty of Health Sciences, University of Tromsø, 9037, Tromsö, Norway.; Northern Norway Regional Health Authority Trust, 8006, Bodø, Norway.
Source:	Medical oncology (Northwood, London, England) [Med Oncol] 2017 Sep; Vol. 34 (9), pp. 149. Date of Electronic Publication: 2017 Jul 26.
Publication Type:	Journal Article
Journal Info:	Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1559-131X
DOI:	10.1007/s12032-017-1002-6